4FERRUCCI PF,ZUCCA E.Primary gastric lymphoma pathogenesisand treatment:what has changed over the past 10 years[J]?Br JHaematol,2007,136:521-538.
5HIDDEMANNW,UNTERHALTM,HERRMANNR,et al.Mantle-cell lymphomas have more widespread with follicle-centre lympho-mas:results of a prospective comparative analysis of the Germanlow-grade lymphoma study group[J].J Clin Oncol,1998,16:1922-1930.
6HUNTJP,CHANJA,SAMOSZUKM,et al.Hyperplasia of mantle/marqinal zone B-cells with clear cytoplasrn in peripheral lymph-nodes.A clini copathologic study of 35cases[J].Am J Clin Pathol,2001,116:550-559.
7Bang Y J,Van Cutsem E,Feyereislova A,et al.Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA):a phase 3,open-label,randomised controlled trial[J].Lancet,2010,376(9742):687-697.
8Fulda S,Galluzzi L,Kroemer G.Targeting mitochondria for cancer therapy[J].Nat Rev Drug Discov,2010,9(6):447-464.
9Dhar S,Kolishetti N,Lippard S J,et al.Targeted delivery of a cisplatin prodrug for safer and more effective prostate cancer therapy in vivo[J].Proc Natl Acad Sci USA,2011,108(5):1850-1855.
10Moore T A,Berger A M,Dizona P.Sleep aid use during and following breast cancer adjuvant chemotherapy[J].Psycho-Oncol,2011,20(3):321-325.
